Facebook
X
LinkedIn
ForwardUtilization of a Diagnosis Coding Reference Guide for Anaphylaxis (Non-CME)
Anaphylaxis requires timely recognition and precise documentation to ensure appropriate care and coverage. This webinar will highlight a structured coding reference guide and practical approaches for capturing clinical specificity and applying accurate diagnosis codes. It will also address how coding impacts patient outcomes, care coordination, and reimbursement
Join experts David Fleischer, MD, J. Wesley Sublett, MD, MPH, and Anna Nowak-Wegrzyn, MD, PhD as they discuss practical approaches to improving anaphylaxis documentation and diagnosis coding. The non-CME webinar will feature downloadable resources developed in collaboration with Theresa Bingemann, MD and Michael Pistiner, MD, MMSc.
This activity is sponsored by a medical education grant from ARS Pharmaceuticals, Inc.
This activity is not certified for CME credit. This webinar is free to members and non-members.
Target Audience
This activity is intended for allergists, allergy advance practice providers, and primary care providers.
Learning Objectives
After participating in this education, learners should be able to:
- Recognize and accurately identify the clinical signs and symptoms of anaphylaxis, including its various presentations and triggers and document anaphylaxis cases comprehensively and precisely, specifying the cause (e.g., food, medication, insect sting), severity, and encounter type (initial, subsequent, sequela).
- Understand and apply the appropriate ICD-10-CM codes for anaphylaxis, selecting the correct codes based on clinical documentation and coding guidelines and navigate the complexity of anaphylaxis coding, including the use of extensions and modifiers to reflect the clinical scenario accurately.
- Appreciate the importance of accurate anaphylaxis coding for patient care quality, safety, research, and healthcare reimbursement.
David M. Fleischer, MD, FACAAI
Children's Hospital Colorado
Dr. David Fleischer completed his undergraduate training at the University of Pennsylvania, medical degree training at Emory University School of Medicine, and both Pediatric Residency and Pediatric Allergy/Immunology Fellowship training at The Johns Hopkins University School of Medicine. Dr. Fleischer is currently the Section Head of Allergy & Immunology at Children’s Hospital Colorado (CHCO) and a Professor of Pediatrics at CHCO and the University of Colorado Denver School of Medicine. He is the Director of the Allergy and Immunology Center at CHCO. Dr. Fleischer is a nationally and internationally renowned food allergy expert, specializing in the diagnosis, management, and prevention of food allergy. His clinical research has focused on the natural history and novel treatments of food allergy, including oral, sublingual, and epicutaneous immunotherapies. He is the Global PI for several Phase III peanut epicutaneous immunotherapy trials that are being conducted at more than 30 sites across the world. He has authored many original, peer-reviewed articles, review articles, and book chapters on food allergy and food allergy treatment.
J. Wesley Sublett, MD, MPH, FACAAI
Family Allergy & Asthma
Wes Sublett, MD, MPH, is a partner and medical director of clinical research at Family Allergy & Asthma, based in Louisville, Kentucky. He is a graduate of Saint Louis University (MPH) and the University of Louisville School of Medicine. Board certified in both pediatrics and allergy/immunology, Dr. Sublett completed his internship and residency in pediatrics at the University of Louisville – Kosair Children’s Hospital. He completed his fellowship in allergy, asthma, and immunology at the University of Cincinnati. He played a crucial role in getting a Kentucky House Bill passed that allows schools to purchase and store epinephrine auto-injectors and use them on children who fall into a life-threatening anaphylactic shock. Dr. Wes was present when Governor Beshear signed the bill into law in 2013. In addition, Dr. Wes is the Medical Director of the Family Allergy & Asthma Research Institute.
Anna Nowak-Wegrzyn, MD, PhD, FACAAI
NYU R. Grossman School of Medicine
Pediatric Allergy and Immunology, Hassenfeld Children's Hospital
Anna Nowak-Wegrzyn, M.D., PhD, FAAAAI, FACAAI, is a Professor of Pediatrics at the NYU Grossman School of Medicine, and the Director of the Pediatric Allergy and Immunology Division, Department of Pediatrics, the Hassenfeld Children’s Hospital, New York, NY. Her research interests focus on baked milk and baked egg diets, food-induced anaphylaxis in children, novel diagnostic and therapeutic approaches to food allergy (OIT, SLIT, EPIT), oral tolerance, and FPIES. She served as a director of the ABAI, 2017-2022 and AAAAI, 2022-. She is the Associate Editor for the Annals of Allergy, Asthma and Immunology, the official journal of the ACAAI.